Nevro Corp

NYSE:NVRO   11:09:08 AM EDT
157.07
+2.11 (+1.36%)
Products, Other Pre-Announcement

Nevro Announces FDA Approval Of Its 10 kHz High Frequency Spinal Cord Stimulation Therapy

Published: 07/19/2021 13:02 GMT
Nevro Corp (NVRO) - Nevro Announces FDA Approval of Its 10 Khz High Frequency Spinal Cord Stimulation Therapy for Treatment of Chronic Pain Associated With Painful Diabetic Neuropathy (pdn).
Q2 Revenue $102.3 Million Versus Refinitiv Ibes Estimate of $102.7 Million.
Will Immediately Initiate Commercial Launch Activities in U.S.continues to Anticipate a Mid-single Digit Million Revenue Contribution From Pdn in 2021, Majority of Which is Expected to Be Generated in Q4.